Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 51 | 14/07/08 | |
Director of Finance/CFO | 51 | 02/03/22 | |
Patrick Sartore
PSD | President | 49 | 01/01/06 |
Gary Bridger
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/05/19 |
Director/Board Member | 67 | 14/05/14 | |
Shrinal Inamdar
IRC | Investor Relations Contact | - | - |
Marie Iskra
LAW | General Counsel | 48 | 01/09/19 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Gary Bridger
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/05/19 |
Director/Board Member | 67 | 14/05/14 | |
Alek Krstajic
CHM | Chairman | 60 | 01/09/20 |
Neil Klompas
BRD | Director/Board Member | 52 | 01/05/19 |
Eugene Siklos
BRD | Director/Board Member | 60 | 01/09/20 |
Director/Board Member | 63 | 01/05/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 3 249 534 | 1 258 903 ( 38,74 %) | 0 | 38,74 % |
Coordinate società
Liminal BioSciences, Inc.
440, boulevard Armand-Frappier Suite 300
H7V 4B4, Laval
+450 781 0115
http://www.liminalbiosciences.com![Indirizzo Liminal BioSciences Inc.(LMNL)](https://cdn.zonebourse.com/static/address/64156495.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+18,09% | 44,48 Mrd | |
+44,19% | 40,57 Mrd | |
-8,38% | 38,82 Mrd | |
+34,66% | 32,22 Mrd | |
-8,34% | 27,84 Mrd | |
+16,10% | 26,79 Mrd | |
+49,73% | 14,31 Mrd | |
+36,71% | 12,7 Mrd | |
-6,60% | 11,23 Mrd |